Health
Cats point the way to potential COVID-19 remedies – FierceBiotech
University of Alberta scientists reported that a drug being developed by Anivive Lifesciences to treat feline infectious peritonitis prevented human coronaviruses from replicating in cell studies. They believe the drug should be rushed into human trials to tr…
Last week, Gilead Sciences said it would test its COVID-19 drug remdesivir against a related compound in its library called GS-441524 in animal trials, after facing scrutiny over the latter drug, which has been used for years to treat feline infectious peritonitis (FIP) despite not being licensed for that use.
Now, another California biotech, Anivive Lifesciences, is working on a COVID-19 antiviral drug thats inspired by cats, and it has new preclinical research findings to back up the project….
-
Business20 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General17 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News8 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
Noosa News20 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success